Sentences with phrase «on epipen»

If you are like me and rely on an EpiPen to keep you or your child safe from a life - threatening allergic reaction, you've probably left the pharmacy thinking, «That's outrageous for such an essential drug.»

Democratic Missouri U.S. Sen. Claire McCaskill said she expects Congress to hold hearings on the EpiPen price increases.

It will also prepare the Resident Advisor (RA) to be trained on EpiPen administration, and to ensure that other students in that area of the dorm are aware of which foods shouldn't be eaten.

They either didn't want the liability of a child with severe food allergies, or they said they weren't willing to be trained on the EpiPen.

Because people with severe allergies rely on the EpiPen, they have no choice but to pony up.

UPDATE: On 9/21/16, the House Oversight Committee grilled Mylan and the FDA in a hearing on the EpiPen price hike.

Mylan is already facing competition from a number of companies ever since the backlash to its massive price hike on the EpiPen.

With rebates, the insurance company (or employer) is still paying just as much on EpiPen claims as it was before.

For the past five years, Medicaid has spent nearly $ 800 million on EpiPens.

Not exact matches

TORONTO, April 17 (Reuters)- Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.'s EpiPen emergency allergy antidote amid a global shortage that has spared the United States.

The company previously said it was relying on guidance from CMS about how it classifies EpiPen for the rebate program.

TORONTO, April 17 - Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.» s EpiPen emergency allergy antidote amid a growing shortage that has spared the United States.

For more on Bresch, read Fortune's 2015 feature, «Why Wall Street Loves to Hate Mylan's CEO» and «Why the CEO Behind the EpiPen Controversy Remains One of Fortune's Most Powerful Women.»

In a statement to CNBC, Mylan reiterated that it was following guidance from the federal government on the classification of EpiPens and it referred to a new government rule that intends to clarify ambiguities in Medicaid rebate law.

Mylan saw its stock dip almost a third of a percent during after - hours trading, following members of Congress saying it cheated taxpayers by underpaying Medicaid in rebates owed on sales of its lifesaving device EpiPen.

Its brand has become synonymous with Kleenex and other household products when it comes to fighting deadly allergies; in fact, the EpiPen enjoys a near - monopoly on the market with annual sales of more than $ 1.3 billion and nearly 90 % U.S. market share in the space.

The generic drug company tripled the discount patients can receive on the cost of EpiPen to $ 300, up from the maximum $ 100 Mylan had previously offered with the use of its special «savings card.»

Even after the outrage the drug faced, the price of the branded EpiPen hasn't changed, Duhigg noted on a recent trip to the pharmacy, though the company did introduce a generic that has a list price of $ 300.

The EpiPen has to be replaced on a yearly basis, ensuring the company a continuous trickle of dedicated customers with few other options.

And despite the fact that Mylan raised EpiPen prices roughly 30 % in 2015 while prescription volume also grew 7 %, the company's revenue on the drug actually fell slightly, as the other players took even bigger cuts, according to Raffat.

That could have a domino effect on the other middlemen between Mylan and the patient, such as drug distributors, pharmacy benefit managers, and pharmacies, who might also have to settle for less revenue per EpiPen sale.

And the risk of losing money also falls less on Mylan than it does on those at the end of the supply chain, with the pharmacy having to dispense EpiPens while accepting less in copay money upfront, then applying for a rebate and waiting to see what trickles back.

Those middlemen are by no means starving: Mylan revealed on Thursday that it wasn't pocketing the full $ 608 EpiPen wholesale price in the first place, but only $ 274 per prescription, with the remaining $ 334 split between the other parties.

Cosmopolitan reports that keeping an EpiPen on your person is good for emergencies.

A test for the shares looms on Wednesday, when Mylan CEO Heather Bresch testifies before the U.S. House of Representatives Oversight Committee over price increases of EpiPen, an auto - injector of allergy medicine.

«I absolutely believe that if EpiPen had to be the catalyst to show this window of what families are facing in a high - deductible plan... then it would have been worth it,» the controversial big pharma chief told attendees at the Forbes Healthcare summit on Thursday.

Shares of Mylan (myl) are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment.

After all, Mylan acquired the EpiPen from another company, and while Bresch insists that significant improvements have been made to the epinephrine - delivering product itself, she also admitted on Thursday that a big part of the price increase rationale was to fund marketing and awareness efforts for the device.

Mylan CEO Heather Bresch trekked to the House of Representatives on Wednesday to testify about her company's controversial price hike for the EpiPen.

Clinton went on to reiterate her position that drug price hikes should be linked with better patient outcomes and demonstrated improvements in value, and demanded that Mylan «immediately reduce the price of EpiPens.»

On Wednesday, the Senate Special Committee on Aging, which has investigated price increases by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the EpiPen's pricing and market share since 200On Wednesday, the Senate Special Committee on Aging, which has investigated price increases by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the EpiPen's pricing and market share since 200on Aging, which has investigated price increases by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the EpiPen's pricing and market share since 2007.

She poured marketing resources into the product, and embarked on an awareness and political campaign to get more EpiPens into schools and other public institutions.

Mylan predicated discounts to pharmacy benefits managers and government health payers like Medicaid on the condition that they would not cover EpiPen alternatives such as Auvi - Q.

While the drug maker has responded to the massive backlash over its extravagant price increase on the device by boosting its patient assistance programs and introducing an authorized generic EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.

Pharma giant Mylan's (myl) controversial price hike for the life - saving EpiPen device drew a sharp rebuke from Democratic presidential contender Hillary Clinton on Wednesday.

And on Thursday, Mylan expanded its discount program, offering up to $ 300 off the cost of EpiPen with the use of a special «savings card,» thereby reducing the price for patients paying out - of - pocket by half, the company said.

Her comments came shortly after the Senate Committee on Aging asked Mylan to provide information on the reasoning behind what it called the «drastic» price increase of EpiPen, and the American Medical Association «urge [d]» Mylan to «rein in these exorbitant costs.»

Mylan, already the most dominant maker of epinephrine auto - injectors, now enjoys a near - monopoly on the market since Auvi - Q's withdrawal: After the recall, EpiPen's market share immediately jumped from 85 % to 95 % at the end of last year.

On an earnings call earlier this month, Bresch blamed EpiPen sticker shock in part on ObamacarOn an earnings call earlier this month, Bresch blamed EpiPen sticker shock in part on Obamacaron Obamacare.

Mylan signed on famous spokespeople for EpiPen, including actress Sarah Jessica Parker and celebrity chef Amanda Freitag.

Mylan has raised the price for the EpiPen, an auto - injector device that delivers epinephrine to counteract deadly allergic reactions which must be replaced on a yearly basis, more than 400 % over the last decade, putting families who have high deductible health insurance in a bind.

But now that the Sanofi (snynf) drug is no longer on the market — the company recalled its entire supply last fall, and has since abandoned it — Mylan is looking to ditch contracts that constrained EpiPen's price.

NEW YORK Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.

The commercial also suggested that an EpiPen was a sufficient treatment on its own.

On Wednesday, regulators said the company had most likely overcharged Medicaid by $ 1.27 billion for EpiPens.

In the wake of the 2016 Epipen and Daraprim drug pricing scandals, and as overall prices continue to climb, investors have grown frustrated by a lack of transparency on the part of the industry and believe a stronger message needs to be sent.

Many school cafeterias have students on work / study working in the cafeteria and this can make training about food allergies and EpiPens more difficult.

From the age of 4, he carried his EpiPens on his body when we left home.

You don't want to show up on the first day of school with an EpiPen and trying to tell the teacher how to care for your child while he / she is learning the names of 25 students.

I had to use the Epipen on AJ at the resort cuz we ate chicken at the Japanese Restaurant with peanut sauce.